First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
Data demonstrate efficacy and durability of vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, are on par with autologous CAR-T cell therapies in the confirmatory cohort (N=22) and with ...
The table below comprises the names of units which are part of the latest syllabus for the 2025 exams. These chapters are intact with minor additions. Discovery of Electron, Proton, and Neutron, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback